BTIG Research Raises LifeMD (NASDAQ:LFMD) Price Target to $13.00
LifeMD (NASDAQ:LFMD – Free Report) had its price objective upped by BTIG Research from $11.00 to $13.00 in a research note published on Friday, Benzinga reports. They currently have a buy rating on the stock. A number of other analysts also recently issued reports on LFMD. Cantor Fitzgerald reaffirmed an overweight rating and set a […]
More Stories
Gladstone Investment Co. 4.875% Notes due 2028 (NASDAQ:GAINZ) Short Interest Up 6.7% in October
Gladstone Investment Co. 4.875% Notes due 2028 (NASDAQ:GAINZ – Get Free Report) was the target of a large increase in...
GraniteShares 2x Long COIN Daily ETF (NASDAQ:CONL) Sees Strong Trading Volume – What’s Next?
GraniteShares 2x Long COIN Daily ETF (NASDAQ:CONL – Get Free Report) shares saw unusually-high trading volume on Tuesday . Approximately...
Pharming Group (NASDAQ:PHAR) Shares Gap Down – What’s Next?
Shares of Pharming Group (NASDAQ:PHAR – Get Free Report) gapped down prior to trading on Tuesday . The stock had...
Fluor (NYSE:FLR) Sees Large Volume Increase – What’s Next?
Fluor Co. (NYSE:FLR – Get Free Report) shares saw unusually-strong trading volume on Tuesday . Approximately 968,994 shares changed hands...
Oscar Health (NYSE:OSCR) Shares Up 11.6% – What’s Next?
Oscar Health, Inc. (NYSE:OSCR – Get Free Report)’s stock price was up 11.6% during trading on Tuesday . The company...
Verona Pharma (NASDAQ:VRNA) Shares Up 3.4% – Here’s What Happened
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) traded up 3.4% during mid-day trading on Tuesday . The...